August 1, 2025Cancer MedicineOpen Access

Leukemia Burden Impacts the Efficacy and Toxicity of Blinatumomab in Pediatric B‐Cell Acute Lymphoblastic Leukemia

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Real-world study shows blinatumomab improves complete remission rates in pediatric B-ALL, suggesting lower leukemia burden enhances outcomes.

Patients with lower leukemia burden before treatment achieved higher overall survival rates than those with a higher burden, indicating treatment efficacy.
Among patients with > 5% blasts prior to treatment, 75.9% achieved complete remission, underlining blinatumomab's effectiveness in managing advanced cases.
Efficacy was measured in terms of minimal residual disease negativity, with 98.9% achieving this status in the MRD+ group, showing treatment success.
41.4% of patients experienced grade ≥ 3 adverse events, predominantly hematological toxicity, signaling a need for monitoring during treatment.

Yan et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

August 1, 2025Cancer MedicineOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Real-world study shows blinatumomab improves complete remission rates in pediatric B-ALL, suggesting lower leukemia burden enhances outcomes.

Patients with lower leukemia burden before treatment achieved higher overall survival rates than those with a higher burden, indicating treatment efficacy.
Among patients with > 5% blasts prior to treatment, 75.9% achieved complete remission, underlining blinatumomab's effectiveness in managing advanced cases.
Efficacy was measured in terms of minimal residual disease negativity, with 98.9% achieving this status in the MRD+ group, showing treatment success.
41.4% of patients experienced grade ≥ 3 adverse events, predominantly hematological toxicity, signaling a need for monitoring during treatment.

Yan et al. (2025) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark